Regeneron Pharma (REGN) PT Raised to $525 at Oppenheimer
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $843.47 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 2
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 2
Join SI Premium – FREE
Oppenheimer analyst Hartaj Singh raised the price target on Regeneron Pharma (NASDAQ: REGN) to $525.00 (from $450.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Halfords Group Plc. (HFD:LN) (HLFDF) PT Raised to GBP2.85 at Canaccord
- BRP Inc. (DOO:CN) (DOOO) PT Raised to Cdn$92 at Canaccord
- Docusign Inc. (DOCU) PT Raised to $72 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
